These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34340059)

  • 1. Conjugation of oxaliplatin with PEGylated-nanobody for enhancing tumor targeting and prolonging circulation.
    Li L; Zhu Y; Liu M; Jin D; Zhang L; Cheng J; Liu Y
    J Inorg Biochem; 2021 Oct; 223():111553. PubMed ID: 34340059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustered nanobody-drug conjugates for targeted cancer therapy.
    Wu T; Liu M; Huang H; Sheng Y; Xiao H; Liu Y
    Chem Commun (Camb); 2020 Aug; 56(65):9344-9347. PubMed ID: 32672289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
    Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
    Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
    [No Abstract]   [Full Text] [Related]  

  • 4. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular design of nanobody-drug conjugates for targeted-delivery of platinum anticancer drugs with an MRI contrast agent.
    Huang H; Wu T; Shi H; Wu Y; Yang H; Zhong K; Wang Y; Liu Y
    Chem Commun (Camb); 2019 Apr; 55(35):5175-5178. PubMed ID: 30984937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting.
    Stefan N; Zimmermann M; Simon M; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2014 Dec; 25(12):2144-56. PubMed ID: 25350699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy.
    Fu Y; Kong Y; Li X; Cheng D; Hou Y; Li Y; Li T; Xiao Y; Zhang Q; Rong R
    Drug Deliv; 2023 Dec; 30(1):2171158. PubMed ID: 36744299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling.
    Wang J; Cao W; Zhang W; Dou B; Ding X; Wang M; Ma J; Li X
    J Med Chem; 2024 May; 67(10):8296-8308. PubMed ID: 38739678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term storage of PEGylated liposomal oxaliplatin with improved stability and long circulation times in vivo.
    Doi Y; Shimizu T; Ishima Y; Ishida T
    Int J Pharm; 2019 Jun; 564():237-243. PubMed ID: 31002935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
    Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
    J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.
    Thiabaud G; He G; Sen S; Shelton KA; Baze WB; Segura L; Alaniz J; Munoz Macias R; Lyness G; Watts AB; Kim HM; Lee H; Cho MY; Hong KS; Finch R; Siddik ZH; Arambula JF; Sessler JL
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7021-7029. PubMed ID: 32179677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the Orientation, Density, and Flexibility of Single-Domain Antibodies on Nanoparticles To Improve Cell Targeting.
    Yong KW; Yuen D; Chen MZ; Johnston APR
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5593-5600. PubMed ID: 31917547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody".
    Sharifi J; Khirehgesh MR; Akbari B; Soleymani B; Mansouri K
    Mol Biotechnol; 2021 Jun; 63(6):525-533. PubMed ID: 33772436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment.
    Al-Mansoori L; Al Qahtani AD; Elsinga P; Goda SK
    Technol Cancer Res Treat; 2021; 20():15330338211057371. PubMed ID: 34802309
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-Responsive Polymeric Nanocomplex for Delivery of Cytotoxic Protein and Chemotherapeutics.
    Lim WQ; Phua SZF; Zhao Y
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31638-31648. PubMed ID: 31389684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
    Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.